AAAAAA

   
Results: 1-25 | 26-26
Results: 1-25/26
The implication of compromised renal function at presentation in myeloma -Similar outcome in Patients who receive high-dose therapy: A single-centerstudy of 251 previously untreated patients
Authors: Sirohi, B Powles, R Mehta, J Treleaven, J Raje, N Kulkarni, S Rudin, C Bhagwati, N Horton, C Saso, R Singhal, S Parikh, P
Citation: B. Sirohi et al., The implication of compromised renal function at presentation in myeloma -Similar outcome in Patients who receive high-dose therapy: A single-centerstudy of 251 previously untreated patients, MED ONCOL, 18(1), 2001, pp. 39-50
Preconcentration of natural protactinium (Pa-231) from monazite on Dowex IX8 and subsequent determination by gamma-spectrometry
Authors: Raje, N Swain, KK Kumar, SA Kayasth, SR Parthasarathy, R Mathur, PK
Citation: N. Raje et al., Preconcentration of natural protactinium (Pa-231) from monazite on Dowex IX8 and subsequent determination by gamma-spectrometry, J RAD NUCL, 247(1), 2001, pp. 115-120
A 50-year-old man with marked splenomegaly and anemia - Lymphoplasmacytic lymphoma. Waldenstrom's macroglobulinemia. Hyperviscosity syndrome. Cryoglobulinemia.
Authors: Raje, N Ferry, JA Arany, ZP Drucker, EA Bloch, KJ Cutler, CS
Citation: N. Raje et al., A 50-year-old man with marked splenomegaly and anemia - Lymphoplasmacytic lymphoma. Waldenstrom's macroglobulinemia. Hyperviscosity syndrome. Cryoglobulinemia., N ENG J MED, 345(9), 2001, pp. 682-687
Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration
Authors: Podar, K Tai, YT Davies, FE Lentzsch, S Sattler, M Hideshima, T Lin, BK Gupta, D Shima, Y Chauhan, D Mitsiades, C Raje, N Richardson, P Anderson, KC
Citation: K. Podar et al., Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration, BLOOD, 98(2), 2001, pp. 428-435
Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma
Authors: Davies, FE Raje, N Hideshima, T Lentzsch, S Young, G Tai, YT Lin, B Podar, K Gupta, D Chauhan, D Treon, SP Richardson, PG Schlossman, RL Morgan, GJ Muller, GW Stirling, DI Anderson, KC
Citation: Fe. Davies et al., Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma, BLOOD, 98(1), 2001, pp. 210-216
Kaposi's sarcoma-associated herpesvirus gene sequences are detectable at low copy number in primary amyloidosis
Authors: Raje, N Kica, G Chauhan, D Zhang, YN Teoh, G Treon, SP Hideshima, T Deng, JH Gao, SJ Alsina, M Wally, J Davies, FE Tai, YT Pinkus, GS Pinkus, JL Skinner, M Comenzo, RL Anderson, KC
Citation: N. Raje et al., Kaposi's sarcoma-associated herpesvirus gene sequences are detectable at low copy number in primary amyloidosis, AMYLOID, 7(2), 2000, pp. 126-132
Characterization of signaling cascades triggered by human interleukin-6 versus Kaposi's sarcoma-associated herpes virus-encoded viral interleukin 6
Authors: Hideshima, T Chauhan, D Teoh, G Raje, N Treon, SP Tai, YT Shima, Y Anderson, KC
Citation: T. Hideshima et al., Characterization of signaling cascades triggered by human interleukin-6 versus Kaposi's sarcoma-associated herpes virus-encoded viral interleukin 6, CLIN CANC R, 6(3), 2000, pp. 1180-1189
The Hu/Yahalom article reviewed
Authors: Raje, N Anderson, KC
Citation: N. Raje et Kc. Anderson, The Hu/Yahalom article reviewed, ONCOLOGY-NY, 14(1), 2000, pp. 112
Acute lymphoblastic leukaemia-type intensive chemotherapy to eliminate minimal residual disease after high-dose melphalan and autologous transplantation in multiple myeloma - a phase I/II feasibility and tolerance study of 17 patients
Authors: Powles, R Sirohi, B Kulkarni, S Bhagwati, N Saso, R Raje, N Horton, C Singhal, S Mehta, J Treleaven, J
Citation: R. Powles et al., Acute lymphoblastic leukaemia-type intensive chemotherapy to eliminate minimal residual disease after high-dose melphalan and autologous transplantation in multiple myeloma - a phase I/II feasibility and tolerance study of 17 patients, BONE MAR TR, 25(9), 2000, pp. 949-956
Immunotherapeutic strategies for the treatment of plasma cell malignancies
Authors: Treon, SP Raje, N Anderson, KC
Citation: Sp. Treon et al., Immunotherapeutic strategies for the treatment of plasma cell malignancies, SEMIN ONCOL, 27(5), 2000, pp. 598-613
Ku86 variant expression and function in multiple myeloma cells is associated with increased sensitivity to DNA damage
Authors: Tai, YT Teoh, G Lin, B Davies, FE Chauhan, D Treon, SP Raje, N Hideshima, T Shima, Y Podar, K Anderson, KC
Citation: Yt. Tai et al., Ku86 variant expression and function in multiple myeloma cells is associated with increased sensitivity to DNA damage, J IMMUNOL, 165(11), 2000, pp. 6347-6355
Isolation and characterization of human multiple myeloma cell enriched populations
Authors: Tai, YT Teoh, G Shima, Y Chauhan, D Treon, SP Raje, N Hideshima, T Davies, FE Anderson, KC
Citation: Yt. Tai et al., Isolation and characterization of human multiple myeloma cell enriched populations, J IMMUNOL M, 235(1-2), 2000, pp. 11-19
SHP2 mediates the protective effect of interleukin-6 against dexamethasone-induced apoptosis in multiple myeloma cells
Authors: Chauhan, D Pandey, P Hideshima, T Treon, S Raje, N Davies, FE Shima, Y Tai, YT Rosen, S Avraham, S Kharbanda, S Andersons, KC
Citation: D. Chauhan et al., SHP2 mediates the protective effect of interleukin-6 against dexamethasone-induced apoptosis in multiple myeloma cells, J BIOL CHEM, 275(36), 2000, pp. 27845-27850
Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy
Authors: Hideshima, T Chauhan, D Shima, Y Raje, N Davies, FE Tai, YT Treon, SP Lin, B Schlossman, RL Richardson, P Muller, G Stirling, DI Anderson, KC
Citation: T. Hideshima et al., Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy, BLOOD, 96(9), 2000, pp. 2943-2950
Elevated soluble MUC1 levels and decreased anti-MUC1 antibody levels in patients with multiple myeloma
Authors: Treon, SP Maimonis, P Bua, D Young, G Raje, N Mollick, J Chauhan, D Tai, YT Hideshima, T Shima, Y Hilgers, J von Mensdorff-Pouilly, S Belch, AR Pilarski, LM Anderson, KC
Citation: Sp. Treon et al., Elevated soluble MUC1 levels and decreased anti-MUC1 antibody levels in patients with multiple myeloma, BLOOD, 96(9), 2000, pp. 3147-3153
Introduction: the evolving role of bisphosphonate therapy in multiple myeloma
Authors: Raje, N Anderson, KC
Citation: N. Raje et Kc. Anderson, Introduction: the evolving role of bisphosphonate therapy in multiple myeloma, BLOOD, 96(2), 2000, pp. 381-383
CD40 activation mediates p53-dependent cell cycle regulation in human multiple myeloma cell lines
Authors: Teoh, G Tai, YT Urashima, M Shirahama, S Matsuzaki, M Chauhan, D Treon, SP Raje, N Hideshima, T Shima, Y Anderson, KC
Citation: G. Teoh et al., CD40 activation mediates p53-dependent cell cycle regulation in human multiple myeloma cell lines, BLOOD, 95(3), 2000, pp. 1039-1046
Preconcentration and determination of mercury in high purity arsenic
Authors: Swain, K Raje, N Kayasth, S
Citation: K. Swain et al., Preconcentration and determination of mercury in high purity arsenic, ANALYT CHIM, 405(1-2), 2000, pp. 297-301
Oral idarubicin as a single agent therapy in patients with relapsed or resistant multiple myeloma
Authors: Sumpter, K Powles, RL Raje, N Ramiah, V Kulkarni, S Treleaven, J Mainwaring, PN
Citation: K. Sumpter et al., Oral idarubicin as a single agent therapy in patients with relapsed or resistant multiple myeloma, LEUK LYMPH, 35(5-6), 1999, pp. 593-597
RAFTK/PYK2-dependent and -independent apoptosis in multiple myeloma cells
Authors: Chauhan, D Hideshima, T Pandey, P Treon, S Teoh, G Raje, N Rosen, S Krett, N Husson, H Avraham, S Kharbanda, S Anderson, KC
Citation: D. Chauhan et al., RAFTK/PYK2-dependent and -independent apoptosis in multiple myeloma cells, ONCOGENE, 18(48), 1999, pp. 6733-6740
Thalidomide - A revival story.
Authors: Raje, N Anderson, K
Citation: N. Raje et K. Anderson, Thalidomide - A revival story., N ENG J MED, 341(21), 1999, pp. 1606-1609
Functional interaction between retinoblastoma protein and stress-activatedprotein kinase in multiple myeloma cells
Authors: Chauhan, D Hideshima, T Treon, S Teoh, G Raje, N Yoshihimito, S Tai, YT Li, WW Fan, JG DeCaprio, J Anderson, KC
Citation: D. Chauhan et al., Functional interaction between retinoblastoma protein and stress-activatedprotein kinase in multiple myeloma cells, CANCER RES, 59(6), 1999, pp. 1192-1195
Complete remission rate and outcome after intensive treatment of 177 patients under 75 years of age with IgG myeloma defining a circumscribed diseaseentity with a new staging system
Authors: Sirohi, B Powles, R Mehta, J Raje, N Kulkarni, S Ramiah, V Saso, R Horton, C Bhagwati, N Singhal, S Treleaven, J
Citation: B. Sirohi et al., Complete remission rate and outcome after intensive treatment of 177 patients under 75 years of age with IgG myeloma defining a circumscribed diseaseentity with a new staging system, BR J HAEM, 107(3), 1999, pp. 656-666
Detection of Kaposi's sarcoma herpesvirus DNA sequences in multiple myeloma bone marrow stromal cells
Authors: Chauhan, D Bharti, A Raje, N Gustafson, E Pinkus, GS Pinkus, JL Teoh, G Hideshima, T Treon, SP Fingeroth, JD Anderson, KC
Citation: D. Chauhan et al., Detection of Kaposi's sarcoma herpesvirus DNA sequences in multiple myeloma bone marrow stromal cells, BLOOD, 93(5), 1999, pp. 1482-1486
Bone marrow and peripheral blood dendritic cells from patients with multiple myeloma are phenotypically and functionally normal despite the detectionof Kaposi's sarcoma herpesvirus gene sequences
Authors: Raje, N Gong, JL Chauhan, D Teoh, G Avigan, D Wu, ZK Chen, DS Treon, SP Webb, IJ Kufe, DW Anderson, KC
Citation: N. Raje et al., Bone marrow and peripheral blood dendritic cells from patients with multiple myeloma are phenotypically and functionally normal despite the detectionof Kaposi's sarcoma herpesvirus gene sequences, BLOOD, 93(5), 1999, pp. 1487-1495
Risultati: 1-25 | 26-26